Copyright
        ©2014 Baishideng Publishing Group Inc.
    
    
        World J Gastroenterol. Aug 14, 2014; 20(30): 10331-10337
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10331
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10331
            Table 1 Effects of cure of Helicobacter pylori infection on l-dopa absorption and/or symptoms scores in patients with Parkinson’s disease
        
    | Ref. | Study design (level of evidence)1 | n | Helicobacter pylori positivity | Intervention | Outcome measure | Effect of eradicaction treatment | 
| Benvenga et al[20] | Crossover study (4) | 6 | Serology | Eradication tx vs placebo | AUC of | 21% increase after eradication treatment | 
| L-dopa | No variation after placebo | |||||
| Pierantozzi et al[10] | RCT (1) | 34 | Serology, stool test, CP-test or culture | Eradication tx vs antioxidant tx (allopurinol) | AUC of | 54% increase after eradication treatment | 
| L-dopa | No variation after antioxidant tx | |||||
| Lee et al[11] | Case series (3) | 65 | Urea breath test | Eradication tx | UPDRS-III | No variation | 
| L-dopa "onset" and "on-time" | 25.9% decrease and 11.9% increase after eradication tx | 
- 
        Citation: Lahner E, Virili C, Santaguida MG, Annibale B, Centanni M. Helicobacter pylori infection and drugs malabsorption. World J Gastroenterol 2014; 20(30): 10331-10337
- URL: https://www.wjgnet.com/1007-9327/full/v20/i30/10331.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i30.10331

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        